@FiercePharma: Krystexxa sales still aren't taking off. Savient says Q4 sales of gout drug only up to $4.7M from $3M. Report | Follow @FiercePharma
@EricPFierce: Italy's the 2nd largest API maker behind China, says Italian expert. Who would have guessed it? India is 3rd. More | Follow @EricPFierce
> FDA Commissioner Margaret Hamburg picked Dr. Kathleen Uhl to serve as acting chief of the agency's generic drugs office; she replaces her former boss, Dr. Gregory Geba, who resigned last week. Report
> Boehringer Ingelheim and Eli Lilly ($LLY) launched a late-stage trial of their diabetes drug Trajenta in patients with kidney damage. Report
> Drug sales in France are expected to continue shrinking this year as the government cuts healthcare spending. Report
> AstraZeneca ($AZN) may consider leasing three lab buildings in Delaware, rather than demolishing them as originally planned, local officials said. Report
> A real estate developer may buy Bayer HealthCare's campus near Wayne, NJ, to market it as an office and R&D facility. Report
> Officials in Malta are working with Actavis to find jobs for the 65 workers laid off there earlier this month. Report
> Worried about their own insurance costs, Texas business groups are lobbying Gov. Rick Perry to sign on to President Obama's Medicaid expansion. Report
Biotech News
@FierceBiotech: Amgen scores PhIII success with BioVex virus against melanoma. More | Follow @FierceBiotech
@JohnCFierce: AstraZeneca feels sting of union backlash against R&D upheaval. Story | Follow @JohnCFierce
@RyanMFierce: Merck slashes data-management costs with China site. Article | Follow @RyanMFierce
> Volatile BioLineRx shares decimated by PhII/III schizophrenia drug failure. Story
> Lone Star biotech banks $11.4M for PhII orphan drug odyssey. Article
> Amgen scores PhIII success with BioVex virus against melanoma. News
@FierceMedDev: Post-PMA, Cardiovascular Systems pursues public offering. More | Follow @FierceMedDev
@MarkHFierce: Spurned by Illumina, Roche may have found a new gene sequencer/Dx company to love. But at what price? Story | Follow @MarkHFierce
@DamianFierce: With election long passed, device tax lobbyists ply Dems. Article | Follow @DamianFierce
> Sorin eyes FDA approval with heart device trial. Article
> SynCardia snags $19M for artificial heart. Report
Biomarkers News
> Luminex to collaborate with Merck on Alzheimer's biomarker diagnostic. Report
> Mount Sinai wins $5M to study vocal disorder biomarkers. Item
> Pee in a cup to diagnose gastroesophageal cancer. More
> GenoMine test spots three new kidney cancer biomarkers. Article
> Texas research team spots Barrett's esophagus biomarkers. Story
Drug Delivery News
@MichaelGFierce: Spectrum picks up orphan cancer drug with stabilized delivery. More | Follow @MichaelGFierce
> New nanomed reduces inflammation in injured tissue by natural means. Story
> Delivery gel releases drugs in response to pressure. More
> Shire bets on PhII protein-delivery therapy to fight infant blindness. Article
> Needle-free ear infection patch delivers bacteria-killing vaccine. Item
And Finally... Several grocery chains have pledged not to sell genetically engineered salmon. Report